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Diesel exhaust particles (DEPs), generated by
heavy-duty diesel engines in various indus-
tries, can adsorb over 450 different organic
compounds, including mutagenic and car-
cinogenic polycyclic aromatic hydrocarbons
(1). With diameters < 2 µm, these fine res-
pirable particles can remain airborne for long
periods of time and deposit in great numbers
deeply in the lungs. For these reasons, expo-
sure of truckers, railroad and construction
workers, and engine mechanics to DEPs is an
occupational health concern. A report from
the U.S. Department of Labor showed that the
worst-case mean exposures to DEPs in under-
ground metal and nonmetal mines are about
2,000 µg/m3, with maximum measurements
as high as 3,650 µg/m3 (2). Epidemiologic
studies have also shown a consistent associa-
tion between elevated levels of particulate
matter in ambient air and increased incidence
of pulmonary infections (3) or increased respi-
ratory mortality and morbidity in high-risk
groups (4,5). Because DEPs are a major com-
ponent of particulate air pollution in most
industrialized urban areas, their effect on pul-
monary infections is of great environmental
and occupational concern.
The principal function of pulmonary host
defense mechanisms is to clear inhaled parti-
cles or microorganisms from the lungs and
prevent infections. Among the various cell
types involved in the innate immune system,
alveolar macrophages (AMs) are responsible
for the clearance of inhaled particles and/or
microorganisms from the distal airways and
alveolar spaces. These cells engulf inhaled par-
ticles or microorganisms and become activated
to release reactive oxygen species (ROS),
cytokines, and a variety of mediators that are
capable of killing microorganisms (6,7). It has
been well documented that AM-derived
proinflammatory cytokines, such as inter-
leukin-1 (IL-1) and tumor necrosis factor-α
(TNF-α), provide innate resistance to bacter-
ial infection, promote the inflammatory
process by recruiting neutrophils into the air
spaces, and stimulate these phagocytes to
release ROS and enzymes (7,8). A successful
pulmonary host defense, on the other hand,
also needs specific cell-mediated immunity
(9). In this aspect, studies have already shown
that AMs, through their secretion of cytokines
in response to speciﬁc antigen exposure, pro-
vide a critical link between these two systems.
For example, Hsieh et al. (10) showed that the
production of IL-12 by macrophages is a key
process for the development of the appropri-
ate CD4+ T helper (Th) subset during the
immune response to Listeria monocytogenes
infection. IL-12, in fact, not only initiates but
also plays an important role in maintaining
the Th1 response (11). This cytokine is pro-
duced very rapidly after infection, thus serving
as an early marker for the study of DEP
effect(s) on cell-mediated immunity.
Studies from our laboratory as well as
from others have suggested that DEPs may
suppress host immunity by suppressing
mucociliary clearance and the phagocytic
activity of AMs (12,13), reducing interferon
production in response to viral infection (14)
and depressing immune responsiveness to
bacterial antigenic stimulation (15,16). In
addition, DEPs were also shown to be capa-
ble of potentiating antigen sensitization with
increased production of antigen-specific
immunoglobulin E (17–19). In a recent
study, we further demonstrated that exposure
to DEPs, but not to carbon black, decreased
pulmonary bacterial clearance in rats, suggest-
ing that DEPs may have an adverse inﬂuence
on both the innate and the T-cell–mediated
immune responses (20). Although we have
previously shown that AMs from DEP-
exposed rats were less responsive to ex vivo
challenge with lipopolysaccharide (LPS) in
the production of IL-1 and TNF-α (16), how
DEPs impair pulmonary host defense mecha-
nisms is not yet well understood. Whether
the cytokine production by AMs is indeed
decreased during a bacterial infection after
DEP exposure remains to be determined.
To test the hypothesis that DEPs aggra-
vate pulmonary bacterial infection by both
innate and cell-mediated immune mecha-
nisms, we have characterized the effect of
short-term DEP exposure on macrophage
functions critical in the immune response to
Listeria infection. Speciﬁcally, these functions
include AM phagocytosis, macrophage secre-
tion of IL-1β and TNF-α for innate immune
responses, and AM production of IL-12, a
proinflammatory cytokine that bridges the
innate resistance and antigen-speciﬁc adaptive
immunity. The acute effect of DEP exposure
Address correspondence to J.K.H. Ma, School of
Pharmacy, West Virginia University, P.O. Box 9530,
1 Medical Center Drive, HSC North, Morgantown,
WV 26506-9530 USA. Telephone: (304) 293-1449.
Fax: (304) 293-2576. E-mail: jma@hsc.wvu.edu
This research was supported in part by grant RO1
HL 62630-02 from the National Heart, Lung, and
Blood Institute.
Received 7 December 2001; accepted 29 March
2002.
Articles
It has been hypothesized that diesel exhaust particles (DEPs) aggravate pulmonary bacterial infec-
tion by both innate and cell-mediated immune mechanisms. To test this hypothesis, we investi-
gated the effects of DEP exposure on the functions of alveolar macrophages (AMs) and
lymphocytes from lung-draining lymph nodes using a rat Listeria monocytogenes infection model.
In the present study, we focused on the effects of DEP exposure on AM functions, including
phagocytic activity and secretion of proinﬂammatory cytokines. The Listeria infection model was
characterized by an increase in neutrophil count, albumin content, and acellular lactate dehydro-
genase activity in the bronchoalveolar lavage (BAL) ﬂuid at 3 and 7 days postinfection. Short-term
DEP inhalation (50 and 100 mg/m3, 4 hr) resulted in a dose-dependent suppression of lung clear-
ance of Listeria, with the highest bacteria count occurring at day 3. This aggravated bacterial
infection was consistent with the inhibitory effect of DEPs on macrophage functions. DEPs sup-
pressed phagocytosis and Listeria-induced basal secretion of interleukin-1β (IL-1β) and IL-12 by
AMs in a dose-dependent manner. The amount of IL-1β and IL-12 in the BAL fluid was also
reduced by DEP exposure. In addition, DEPs decreased Listeria-induced lipopolysaccharide-stim-
ulated secretion of tumor necrosis factor-α (TNF-α), IL-1β, and IL-12 from AMs. These results
suggest that DEPs retard bacterial clearance by inhibiting AM phagocytosis and weaken the innate
immunity by inhibiting AM secretion of IL-1β and TNF-α. DEPs may also suppress cell-medi-
ated immunity by inhibiting AM secretion of IL-12, a key cytokine for the initiation of T helper
type 1 cell development in Listeria infection. Key words: alveolar macrophages, cytokine produc-
tion, diesel exhaust particles, inhalation exposure, Listeria monocytogenes, occupational exposure,
phagocytosis. Environ Health Perspect 110:1105–1111 (2002). [Online 17 September 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p1105-1111yin/abstract.htmlwas studied by exposing rats to 50 or 100
mg/m3 DEPs for 4 hr. Although these doses
appear to be high compared with reported
environmental and occupational levels, the
estimated lung deposits of DEPs under such
short duration were typically 10–20 times less
than those in rats under chronic studies
(21–23). The present study is intended to
assess the early responses to acute DEP expo-
sure, which should provide more insight into
the mechanisms by which DEPs aggravate
pulmonary infection.
Materials and Methods
Materials. A standardized DEP sample (stan-
dard reference material 1650a), representative
of heavy-duty engine emissions, was obtained
from the National Institute of Standards and
Technology (Gaithersburg, MD, USA). This
sample had a mass median aerodynamic
diameter of approximately 0.5 µm. Listeria
was of strain 10403s and serotype 1. Male
Brown-Norway rats (200–250 g body weight)
were purchased from Harlan Laboratories
(Indianapolis, IN, USA). They were housed
in a clean-air and viral-free room with
restricted access, given a conventional labora-
tory diet and tap water ad libitum, and
allowed to acclimate in an animal facility
approved by the Association for Assessment
and Accreditation of Laboratory Animal Care
for 1 week before use. 
DEP inhalation and intratracheal bacter-
ial inoculation. Groups of rats were exposed to
either puriﬁed air or DEP-containing air (50
and 100 mg/m3) for 4 hr using a nose-only
inhalation system that consisted of a nebulizer,
a diffusion dryer, and an inhalation chamber
with 12 ports for animal holding tubes. DEP
suspension in water was sonicated for 10 min,
aerosolized using a nebulizer, and carried by
generated air (carrier air) through a diffusion
dryer. The carrier air was mixed with clean air
(dilution air) from a different air source before
entering the inhalation chamber. Efﬂuent from
the inhalation chamber was passed through a
HEPA ﬁlter to remove particles. The total air
ﬂowing through the inhalation chamber was
regulated by the ﬂow rates of the carrier air and
dilution air. DEP concentrations in the cham-
ber were monitored by gravimetric sampling of
dust collected on a ﬁlter at a sampling rate of
1 L/min. The estimated lung deposits of DEPs
for the 4-hr inhalation exposure, according to
the method of Leong et al. (24), were 194 and
384 µg/rat for 50 and 100 mg/m3 dose groups,
respectively.
Listeria was cultured overnight in brain–
heart infusion broth (Difco Laboratories,
Detroit, MI, USA) at 37°C in a shaking incu-
bator. After incubation, the bacteria concentra-
tion was determined spectrophotometrically at
an optical density of 600 nm and diluted with
sterile saline to the desired concentrations.
Two hours after DEP exposure, rats were
lightly anesthetized with methohexital sodium
(35 mg/kg body weight, intraperitoneally; Eli
Lilly Co., Indianapolis, IN, USA) and inocu-
lated intratracheally with approximately
100,000 Listeria in 500 µL of sterile saline or
with 500 µL of the vehicle alone, according to
the method of Antonini et al. (25).
Bronchoalveolar lavage (BAL) and bio-
chemical assay of BAL ﬂuid. At 3 and 7 days
after bacteria instillation, rats were deeply
anesthetized with an overdose of sodium pen-
tobarbital (50 mg/kg, intraperitoneally;
Butler, Columbus, OH, USA) and then
exsanguinated by severing the abdominal
aorta. The trachea was cannulated, and the
lungs were lavaged with Ca2+/Mg2+-free phos-
phate-buffered solution (PBS; 145 mM NaCl,
5 mM KCl, 1.9 mM NaH2PO4, 9.35 mM
Na2HPO4, and 5.5 mM glucose; pH 7.4) at a
volume of 6 mL for the ﬁrst lavage and 8 mL
for the subsequent lavages. The supernatant of
the ﬁrst lavage (~4 mL/rat) was kept separately
from the others and saved at –70°C for vari-
ous assays. From the subsequent lavages, a
total of 80 mL of bronchoalveolar lavage
(BAL) fluid was collected from each rat and
centrifuged at 500 × g for 10 min at 4°C. All
cell pellets from an individual rat were com-
bined, washed, and resuspended in 1 mL PBS
buffer. The numbers of AMs and neutrophils
in the BAL cell suspension were determined
according to their unique cell diameters (26)
using an electronic cell counter equipped with
a cell-sizing unit (Coulter Electronics,
Hialeah, FL, USA). The remaining BAL cells
were used for primary cell culture to deter-
mine functional activity of the cells, as
described below.
Albumin content, a measure to quantitate
increased permeability of the bronchoalveo-
lar–capillary barrier, and lactate dehydroge-
nase (LDH) activity, an indicator of general
cytotoxicity, were determined in the acellular
BAL ﬂuid from the ﬁrst lavage. Measurements
were performed with an automated Cobas
Fara II analyzer (Roche Diagnostic Systems,
Indianapolis, IN, USA). The albumin content
was determined colorimetrically based on
albumin binding to bromcresol green using an
albumin BCG diagnostic kit (Sigma Chemical
Co., St. Louis, MO, USA). The LDH activ-
ity, expressed as units per liter of BAL ﬂuid,
was determined by measuring the formation
of reduced form of nicotinamide adenine din-
ucleotide using the Roche Diagnostic reagents
and procedures (Roche Diagnostic Systems). 
Pulmonary clearance of Listeria. After
BAL, the lungs were removed from all Listeria-
infected rats and homogenized in 10 mL ster-
ile water using a Polytron 2100 homogenizer
(Brinkmann Instruments, Westbury, NY,
USA). The tissue homogenates or their dilu-
tions were quantitatively plated in triplicate
on brain–heart infusion agar plates and incu-
bated at 37°C overnight. For each plate, the
colony-forming units (CFU), an index of
viable bacteria, were counted using a scanner.
The counts were averaged and corrected for
dilution to yield the CFU per milliliter by a
computer-based program (CIA-BEN V2.2;
Spiral Biotech, Inc., Norwood, MA, USA),
through which the CFU per lung from each
treatment group was determined.
Measurement of phagocytosis. The BAL
cells, 5 × 105 cells/well, were incubated at
37°C for 1 hr in a 24-well plate in PBS with
1% fetal bovine serum (FBS) to allow cell
attachment to glass coverslips. After the incu-
bation period, nonadherent cells were removed
by washing with PBS. The adhered AMs were
treated with carboxylate-modified, yellow-
green FluoSpheres (2.0 µm; Molecular Probes,
Eugene, OR, USA) and rocked at 37°C for 1
hr at a concentration of 30 beads/cell. After the
second incubation period, AMs were washed
twice with PBS to remove any free beads, ﬁxed
with 2% paraformaldehyde overnight, and
stained with 0.1 µg/mL of ﬂuorochrome nile
red (Molecular Probes) for 5 min. The glass
coverslips were mounted on microscope slides,
and images were recorded from a Sarastro
2000 laser scanning confocal microscope ﬁtted
with an argon-ion laser (Molecular Dynamics,
Inc., Sunnyvale, CA, USA) using an excitation
light of 514 nm. This technique allowed for
discrimination of AMs and neutrophils that
adhered to the coverslips. The phagocytic
activity of AMs was expressed using a weighted
phagocytic index (WPI) determined as follows.
Two hundred AMs per rat for each of the
treatment groups were evaluated and scored as
having 0, 1–4, 5–9, 10–14, or > 15 beads/cell.
These scoring groups were assigned to have a
numerical factor of 0, 1, 2, 3, and 4, respec-
tively. The number of AMs in each scoring
group was ﬁrst multiplied by its numerical fac-
tor and then added together for all scoring
groups. This summation was then divided by
200 (total number of cells) to give the WPI.
To ascertain whether the change in phago-
cytic activity was due to a direct interaction of
AMs with DEPs, an in vitro assay was also
performed. Brieﬂy, 5 × 105 AMs isolated from
normal male Brown-Norway rats were treated
with 25–200 µg/mL DEPs for 2 hr or 100
µg/mL DEPs for 1–24 hr in a rocked culture
tube in a humidiﬁed incubator (37°C and 5%
CO2). We used dimethylsulfoxide as a solvent
control. Viability was assessed by trypan blue
exclusion assay, and measurement of phagocy-
tosis was carried out as described above.
Determination of cytokines. BAL cells
recovered from rats were suspended in the
RPMI-1640 medium (Gibco BRL Life
Technologies, Gaithersburg, MD, USA) con-
taining 2 mM glutamine, 100 µg/mL strepto-
mycin, 100 U/mL penicillin, 5 × 10–5 M
Articles • Yin et al.
1106 VOLUME 110 | NUMBER 11 | November 2002 • Environmental Health Perspectives2-β-mercaptoethanol, 5 mM HEPES, and
10% heat-inactivated FBS. Aliquots of 1 mL
cell suspensions, adjusted to 4 × 106 AMs,
were added to each well of 24-well tissue cul-
ture plates (Costar, Cambridge, MA, USA)
and incubated in a humidified incubator
(37°C and 5% CO2) for 1 hr to allow cell
attachment to plastic plate. The nonadherent
BAL cells were then removed by rinsing the
monolayers three times with RPMI medium.
These AM-enriched cells were then treated
with or without LPS (1 µg/mL; Sigma
Chemical Co.) for 24 hr. The AM-condi-
tioned media were collected and centrifuged
(1,200 × g for 4 min) and the supernatants
were aliquoted and stored at –70°C until
assayed. To ensure that the number of adher-
ent cells was the same in various culture sam-
ples, studies were carried out to determine the
cellular protein levels after incubation. The
adherent cells were treated with 0.5% Triton
X-100 at 37°C for 30 min, and the media
were collected and centrifuged. The protein
contents in supernates were determined using
Sigma Diagnostic reagents and procedures
(Sigma Chemical Co.) on a Cobas Fara II
analyzer (Roche Diagnostic Systems). The
results did not show a significant difference
among the samples from various treatment
groups (data not shown).
The concentrations of IL-1β, IL-12, and
TNF-α in the culture media were quantiﬁed
by the enzyme-linked immunosorbent assay
(ELISA) using commercial ELISA kits
(BioSource International, Inc., Camarillo,
CA). The level of detection for each
cytokine measured using the ELISA kit was
31.2–2,000 pg/mL for IL-1β, 7.8–500
pg/mL for IL-12, and 15.6–1,000 pg/mL
for TNF-α. Absorbance was read at 450 nm
with a microplate spectrophotometer reader
(SpectraMax 250; Molecular Devices Co.,
Sunnyvale, CA, USA). The concentrations
of these cytokines in the ﬁrst BAL ﬂuid were
also quantified to provide an assessment of
in vivo cytokine production by AMs.
Statistical analysis. Results are expressed
as mean ± SE of multiple measurements.
Statistical analyses were carried out with the
JMP IN statistical program (SAS, Inc., Cary,
NC, USA). The significance of the interac-
tion among the different treatment groups for
the different parameters at each time point
was assessed using an analysis of variance
(ANOVA). The significance of difference
between individual groups was analyzed using
the Tukey-Kramer’s honestly signiﬁcant dif-
ferent (HSD) test. For all analyses, the crite-
rion of signiﬁcance was set at p < 0.05.
Results
Pulmonary inflammatory responses to
DEPs and Listeria. Intratracheal inoculation
of 100,000 Listeria caused a significant
increase in the number of lavageable neu-
trophils at 3 and 7 days postinfection com-
pared with the noninfected controls.
Significantly increased yield of lavageable
AMs, however, was observed only at 7 days
postinfection in these Listeria-infected ani-
mals (Table 1). Exposure to DEPs alone also
resulted in signiﬁcant increases in the number
of AMs as well as in neutrophil infiltration.
These alterations persisted through 7 days,
and the magnitudes of change increased with
increasing DEP exposure doses. At the higher
DEP dose (100 mg/m3), the number of AMs
and neutrophils in Listeria-infected rats were
2- and 4–7-fold that of the air and nonin-
fected controls, respectively. The yield of
BAL neutrophils from rats exposed to 100
mg/m3 DEPs and Listeria was significantly
higher than those from rats treated with
either DEPs or Listeria alone.
As indices of lung injury, albumin con-
tent and LDH activity were measured in the
acellular BAL fluid (Table 2). Exposure to
DEPs alone did not increase BAL ﬂuid albu-
min levels or LDH activity except at the
higher dose and the 7-day postexposure time
point. The results also show that Listeria
infection alone caused increases in both albu-
min content and LDH activity compared
with the noninfected control. In the high-
dose DEP plus Listeria group, higher albumin
levels and LDH activity were noted above
Listeria alone at 3 days postexposure and for
LDH at 7 days postexposure. There was,
however, a descending trend in these eleva-
tions at day 7, suggesting that the lungs were
recovering from the inﬂammatory injury.
Pulmonary clearance of Listeria. The
effects of DEP exposure on lung clearance of
Listeria are shown in Table 3. Rats exposed to
clean air showed an increased bacterial count
(from 1 × 105 to 4.3 × 105) in the lungs at
day 3 but substantial bacterial clearance at
day 7. In rats exposed to DEPs at 50 and 100
mg/m3, the bacterial counts at day 3 were
more than 2- and 10-fold that of the air con-
trol, respectively. Both increases were statisti-
cally signiﬁcant. At day 7, the bacteria count
for rats exposed to the higher dose of DEPs
was much lower than that at day 3 but
remained significantly elevated compared
with air control.
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Table 1. Effects of DEP exposure and/or Listeria infection on the yield of lavageable AMs and neutrophils
in rats. 
DEP dose 3 Days postexposure 7 Days postexposure
(mg/m3) AM (× 106) Neutrophils (× 106) AM (× 106) Neutrophils (× 106)
Without Listeria
Air 4.48 ± 0.76 1.55 ± 0.12 5.63 ± 0.64 1.78 ± 0.17
50 5.17 ± 0.91 3.16 ± 0.46a 8.70 ± 1.60a 4.10 ± 0.41a
100 8.97 ± 1.04a 10.64 ± 2.15a 10.42 ± 1.89a 7.72 ± 1.79a
With Listeria
Air 4.88 ± 0.49 9.46 ± 0.88b 16.53 ± 1.76b 8.02 ± 0.74b
50 5.79 ± 1.10 8.88 ± 1.39b 15.21 ± 3.31b 7.55 ± 1.42b
100 9.05 ± 1.62a 14.44 ± 1.99a,b 16.68 ± 1.31b 16.10 ± 1.50a,b
See “Materials and Methods” for details. Values are expressed as mean ± SE (n = 5) of cell numbers (× 106); data were
analyzed by one-way ANOVA followed by Tukey-Kramer’s HSD test for multiple mean comparisons for each treatment
group at the same dose and exposure time. 
aSigniﬁcantly different from air controls, p < 0.05. bSigniﬁcantly different from noninfected controls, p < 0.05.
Table 2. Effects of DEP exposure and/or Listeria infection on albumin content and LDH activity in BAL ﬂuid
from rats.
3 Days postexposure 7 Days postexposure
DEP dose Albumin LDH Albumin LDH
(mg/m3) (mg/mL BAL ﬂuid) (U/L BAL ﬂuid) (mg/mL BAL ﬂuid) (U/L BAL ﬂuid)
Without Listeria
Air 0.22 ± 0.03 90.50 ± 4.37 0.19 ± 0.02 68.20 ± 11.80
50 0.27 ± 0.04 116.80 ± 22.52 0.17 ± 0.01 60.00 ± 6.93
100 0.32 ± 0.07 116.00 ± 19.91 0.25 ± 0.03 104.80 ± 7.14a
With Listeria
Air 0.39 ± 0.02b 118.20 ± 6.83b 0.31 ± 0.04b 92.00 ± 17.18b
50 0.35 ± 0.05b 130.60 ± 19.57b 0.30 ± 0.04b 113.60 ± 17.47b
100 0.59 ± 0.05a,b 170.60 ± 18.12a,b 0.44 ± 0.01b 151.40 ± 9.04a,b
See “Materials and Methods” for details. Values are expressed as mean ± SE (n = 5); data were analyzed by one-way
ANOVA followed by Tukey-Kramer’s HSD test for multiple mean comparisons for each treatment group at the same dose
and exposure time. 
aSigniﬁcantly different from air controls, p < 0.05. bSigniﬁcantly different from noninfected controls, p < 0.05.
Table 3. Effects of DEP exposure on pulmonary
clearance of Listeria.
CFU/lung (× 105)
DEP dose Initial 3 Days 7 Days
(mg/m3)i nfection postinfection postinfection
Air 1.0 4.3 ± 1.2 0.2 ± 0.0
50 1.0 9.5 ± 3.1a 0.2 ± 0.1
100 1.0 42.2 ± 7.6a 0.4 ± 0.1a
See “Materials and Methods” for details. Values are
expressed as mean ± SE (n = 5).
aSigniﬁcantly different from air control, p < 0.05.Macrophage phagocytosis. The in vivo
effects of DEP exposure and/or Listeria infec-
tion on the phagocytic activity of AMs are
shown in Figure 1. These results indicate that
at both 3 and 7 days postexposure, the WPI
of AMs was signiﬁcantly lowered as a result of
DEP exposure in a dose-dependent manner.
Listeria infection did not appear to alter the
phagocytic activity of AMs from rats exposed
to either clean air or DEPs. Figure 2 shows
the dose- and time-dependent effects of DEPs
on AM phagocytosis in vitro: the WPI of
AMs decreases with increasing DEP dose and
increasing incubation time. The cells treated
with 100 µg/mL DEPs for 24 hr showed
slightly decreased viability (79%), whereas the
others showed no marked cytotoxicity after
treatment with DEPs at the designed doses at
each time point (viability ranging from 87%
to 98%).
Cytokines in BAL fluid.The concentra-
tions of IL-1β, TNF-α, and IL-12 in BAL
ﬂuid obtained from various treatment groups
are shown in Figure 3. At 3 days postexpo-
sure, Listeria infection resulted in a signiﬁcant
increase in IL-1β in both air-exposed and the
lower-dose DEP-exposed rats. DEP exposure
at the higher dose appeared to enhance IL-1β
levels in the BAL fluid. In the combined
high-dose DEP/Listeria exposure, however,
the concentration of IL-1β was significantly
lower than those in animals exposed to DEP
or Listeria alone. The BAL fluid of control
rats contained relatively low concentrations of
TNF-α. DEP exposure did not affect the
production of TNF-α, but the BAL levels of
TNF-α from Listeria-treated rats were signiﬁ-
cantly higher than those of the noninfected
rats at 3 days postexposure. Listeria infection
strongly induced the production of IL-12 at 3
days postexposure. DEP exposure, which had
little or no effect on the BAL level of IL-12,
signiﬁcantly inhibited Listeria-induced IL-12
production. At day 7, the concentrations of
various cytokines in the BAL fluid from
DEP- and/or Listeria-exposed rats were not
different from the corresponding cytokine
levels obtained from the air-exposed control.
Cytokines in AM-conditioned media. The
effects of DEP exposure on the spontaneous
release of IL-1β, TNF-α, and IL-12 by AMs
from rats with or without Listeria infection
was determined. The high-dose DEP expo-
sure enhanced the spontaneous release of IL-
1β by AMs (Figure 4A). This increase was
dose dependent, and the higher dose of DEP
exposure (100 mg/m3) showed significant
stimulatory effect at both 3 and 7 days post-
exposure. AMs from Listeria-infected rats also
showed increased secretion of IL-1β at 3 days
postinfection. This increase was markedly
suppressed by DEPs at both exposure doses.
The spontaneous release of TNF-α by AMs
was not affected by DEP exposure but was
significantly enhanced by Listeria infection
(Figure 4B) at 3 days postexposure. DEPs
also had no effect on TNF-α secretion in
Listeria-infected rats. At day 7, the sponta-
neous release of TNF-α by AMs from all rats
decreased to near basal level. Figure 4C shows
that DEP exposure alone had no effect on
AM secretion of IL-12. Listeria, on the other
hand, induced AM secretion of IL-12 at 3
days postexposure. In the combined exposure,
however, Listeria-induced IL-12 secretion was
significantly suppressed by DEPs at both 3
and 7 days postexposure.
Figure 5 shows the secretion of IL-1β, IL-
12, and TNF-α by AMs in response to ex vivo
LPS challenge using cells obtained from vari-
ous exposure groups. A comparison of Figures
4 and 5 shows that LPS has a general stimula-
tory effect on AM secretion of these proin-
ﬂammatory cytokines. Listeria-infected AMs,
however, showed an increased response to
LPS in the secretion of IL-1β compared with
the air control (Figure 5A). DEP-exposed
AMs showed little to moderate response to
LPS stimulation. But in the combined expo-
sure group, the Listeria-induced secretion of
IL-1β was significantly reduced by DEPs at
both exposure doses and at 3 and 7 days post-
exposure. Figure 5B shows that the secretion
of TNF-α by AMs under Listeria and/or LPS
stimulation was significantly inhibited by
DEPs in a dose-dependent manner at both 3
and 7 days postexposure. The effect of DEPs
on macrophage secretion of IL-12 is shown in
Figure 5C. Listeria-infected AMs showed
increased response to LPS stimulation in the
production of IL-12 compared with AMs
obtained from air-exposed rats. DEP expo-
sure, which had no effect on the secretion of
IL-12 by noninfected AMs, inhibited the pro-
duction of the same cytokine by AMs from
rats exposed to Listeria. This DEP effect was
found signiﬁcant at the higher DEP exposure
dose at both 3 and 7 days postexposure.
Discussion
Listeria is a Gram-positive, facultative intracel-
lular bacteria. Unlike most typical extracellular
pathogens, Listeria induces both innate (non-
specific) and cell-mediated (antigen-specific)
immune responses upon infection. This distin-
guishing feature of Listeria infection makes it
feasible to serve as an experimental probe to
assess how an immunotoxic xenobiotic affects
both innate and cell-mediated immunity of the
host. Actually, experimental listeriosis has been
a widely accepted method for studying cell-
mediated immune responses (27–29). Several
reports have shown that the Listeria infection
model is also applicable to the respiratory sys-
tem for assessing pulmonary host defense
mechanisms (20,25,30–32) and the impor-
tance of cytokines in resistance to bacterial
infection (33–35). The present study demon-
strates that Listeria induces innate pulmonary
immunity and may initiate T-cell–mediated
immune responses in Brown-Norway rats, thus
allowing one to characterize the mechanism(s)
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Figure 1. The WPI of AMs recovered from rats
exposed to DEPs (50 and 100 mg/m3) with or with-
out Listeria at 3 and 7 days postexposure. Values
are expressed as mean ± SE of the percentage of
air control. 
*Signiﬁcantly different from the corresponding air controls,
p < 0.05.
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Figure 2. Effect of DEPs on the WPI of AMs in vitro. AMs recovered from normal rats were exposed to (A)
25–200 µg/mL DEPs for 2 hr or (B) 100 µg /mL DEPs for 1–24 hr. Values are expressed as mean ± SE of the
percentage of saline control. 
*Signiﬁcantly different from the corresponding saline controls, p < 0.05.
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)by which DEP exposure alters the pulmonary
host defense system.
The present study is intended to show the
effects of acute DEP exposure on the pul-
monary immune/inflammatory responses.
Because the exposure duration was short (4 hr),
relatively high exposure doses (50 and 100
mg/m3) were selected so that the DEP effects
can be clearly analyzed. These doses may
appear to be high compared with the reported
environmental and occupational concentra-
tions, but they in fact result in lung deposits
that are relevant to both nonoccupational and
occupational exposure settings. Based on the
reported values of ventilation rate (0.16 L/min)
and percentage deposition (~10%) for rats (24),
the estimated lung deposit of DEPs for a 4-hr
exposure to 100 mg/m3 is 384 µg. This value is
among the lowest values reported in DEP stud-
ies in rodents. The deposit of 384 µg in the rat
lung is equivalent to a deposit of 96,000 µg in
the human lung. Although the latter seems to
be a large number, it is reachable through
chronic exposure to low doses. The air concen-
tration of DEPs nationwide is relatively low
(~2–5 µg/m3), but in certain urban areas, the
air level of DEPs can be considerable higher. In
the Los Angeles Basin, one estimate has placed
the rate of DEP intake by humans at 300 µg
every 1–3 days (36). Using a percentage deposi-
tion of 25% for humans, one can arrive at a
daily intake of 75 µg and an accumulative value
of 96,000 µg in 3.5 years. This suggests that
even at a considerable rate of pulmonary clear-
ance, it is still possible that in urban areas where
high concentrations of DEPs are found, there is
a signiﬁcant accumulation of DEPs in the lungs
of long-time residents. In occupational settings
such as in certain underground mining sites,
the air DEP concentration may reach as high as
3.65 mg/m3 (2). Even at 1 mg/m3, the daily
deposit of DEPs would be 2,400 µg (deposi-
tion, 25%; ventilation rate, 20 L/min). At this
rate, the accumulated lung deposit of DEPs
would reach the value of 96,000 µg in 40
working days. These calculations demonstrate
that the lung deposits of DEPs from doses used
in the present study are within the potential
concentration range for both nonoccupational
and occupational settings.
Brown-Norway rats were used because of
their applicability to investigations involving
immunologic reactions such as pulmonary
allergic sensitization. These rats exhibited high
resistance to Listeria infection and survived at
initial inoculation doses as high as 600,000
Listeria/rat (data not shown). In the present
study, rats exposed to DEPs or clean air for 4
hr were inoculated with 100,000 bacteria and
maintained for up to 7 days. All rats, including
those exposed to the higher dose of DEPs,
which resulted in the highest lung burden of
bacteria (4.22 × 106 Listeria/lung) at 3 days
postinfection, survived without marked symp-
toms during the entire experimental period.
The short-term DEP exposure via the nose-
only inhalation system was shown to cause
only a moderate inflammatory injury in the
lung. In rats exposed to DEPs only, there was
only a slight increase in LDH activity but with
no significant change in albumin content in
the BAL ﬂuid. This short-term DEP exposure,
however, clearly increased the susceptibility of
rats to Listeria infection because rats exposed to
DEPs and then inoculated with Listeria were
less able to clear bacteria from the lungs than
were rats exposed to clean air at 3 and 7 days
postexposure. These results indicate that
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Figure 3. Concentrations of (A) IL-1β, (B) TNF-α, and (C) IL-12 in BAL ﬂuid recovered from rats exposed to air or DEPs (50 and 100 mg/m3) with or without Listeria
at 3 and 7 days postexposure. Values are expressed as mean ± SE. 
*Signiﬁcantly different from the corresponding air controls, p < 0.05. #Signiﬁcantly different from the corresponding nonexposed controls, p < 0.05.
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Figure 4. Spontaneous release of (A) IL-1β, (B) TNF-α, and (C) IL-12 by AMs from rats exposed to air or DEPs (50 and 100 mg/m3) with or without Listeria and har-
vested at 3 and 7 days postexposure. See “Materials and Methods” for details. Concentrations of the cytokines in the culture media were quantified and
expressed as mean ± SE. 
*Signiﬁcantly different from the corresponding air controls, p < 0.05. #Signiﬁcantly different from the corresponding uninfected controls, p < 0.05.
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*inhaled DEPs can result in cellular functional
changes in rats at concentrations that do not
cause substantial inflammatory injury in the
alveolar space.
Listeria can live within a variety of host
cells, including endothelial and epithelial cells,
as well as some macrophages (37). Studies have
shown that the initial host response to Listeria
involves rapid recruitment of neutrophils and
macrophages to the site of infection and the
activation of natural killer (NK) cells (38).
Activated macrophages have also been shown
to play an important role in killing Listeria
(27,39). Indeed, as a key cell type in the innate
immune system, AMs serve to provide the pri-
mary and ﬁrst line of defense against bacteria
that reach the distal lung. These cells engulf
and, through production of oxygen and nitro-
gen radicals and cytokines, kill the bacteria,
thereby sequestering them from the vulnerable
respiratory membrane (6,7,20). To study the
underlying mechanism involved in the DEP-
compromised defense against respiratory infec-
tion, we have investigated the potential
alteration of macrophage functions by DEPs in
the presence and absence of Listeria infection.
The phagocytic activity of AMs is directly
linked to bacterial clearance. Van Loveren et
al. (31) have shown that exposure to ozone
slows the pulmonary clearance of Listeria in
rats and decreases the number of the bacteria
ingested and killed by AMs. In the present
study, the effect of DEPs on the phagocytic
activity of AMs was assessed, and the results
demonstrate that AM phagocytosis was signiﬁ-
cantly suppressed by inhaled DEPs at 3 and 7
days postexposure (Figure 1). This effect may
be attributed to direct interaction of DEPs
with AMs, as demonstrated by the dose- and
time-dependent inhibition of phagocytosis by
DEPs in in vitro studies (Figure 2). Jakab et al.
(40) have suggested that such an interaction
may involve a suppression of macrophage
membrane receptor-mediated phagocytic
activity. The impairment of phagocytic activity
of DEP-exposed AMs may at least partially
account for the decreased pulmonary clearance
of Listeria in the Brown-Norway rats.
Although the innate immune response is
efﬁcient at limiting the initial spread of infec-
tion, effective clearance of Listeria depends on
acquired T-cell–mediated immunity (28).
Several studies have demonstrated the impor-
tance of cytokines in resistance to Listeria
infection (41,42). Through cytokine secretion,
macrophages play a key role in the acquired
immune system to induce appropriate sequen-
tial reactions against bacterial infection
(43,44). We have previously reported that
AMs exposed to DEPs, both in vitro and in
vivo, showed decreased response to ex vivo LPS
stimulation in the production of IL-1 and
TNF-α (15,16). In the present study, short-
term inhalation exposure to DEPs leads to
lowered concentrations of IL-1β and IL-12 in
the BAL fluid, suggesting that the in vivo
secretion of these cytokines by lung cells from
Listeria-infected rats was inhibited by DEP
exposure (Figure 3). This is consistent with the
data that the spontaneous release of these
cytokines by AMs from Listeria-infected and
DEP-exposed rats was significantly lowered
compared with cytokine release by AMs
obtained from Listeria-infected and air-
exposed rats (Figure 4). Furthermore, although
Listeria-infected AMs showed increased secre-
tion of IL-1β, TNF-α, and IL-12 in response
to ex vivo stimulation by LPS, AMs from rats
also exposed to DEPs were diminished in their
ability to respond to ex vivo LPS challenge.
The DEP effect is particularly clear at the
higher DEP exposure dose. These results show
that AMs respond to Listeria infection with
increased secretion of IL-1β, TNF-α, and IL-
12. In rats preexposed to DEPs, however, the
in vivo production of IL-1β and IL-12 was
suppressed, and AMs exhibited diminished
capacity to respond to an ex vivo stimulation
with LPS in the secretion of IL-1β, IL-12, and
TNF-α.
It has been known that IL-1 and TNF-α
secreted by AMs are necessary for the genera-
tion of a protective immune response against
Listeria (33,45). Studies have also shown that
mice deficient in the 55-kDa TNF receptor
are extremely sensitive to Listeria and suc-
cumb easily to infection (27,28), suggesting
that TNF-α is necessary for the elimination
of Listeria. Both IL-1 and TNF-α activate
NK cells to release interferon-γ (IFN-γ),
which activates macrophages to kill the bacte-
ria. IL-12, on the other hand, has been shown
to play a key role for the initiation of T-
cell–mediated immunity. IL-12 is a het-
erodimeric cytokine first described for its
ability to stimulate IFN-γ production by NK
cells and enhance CD8 cytotoxicity (46,47).
Among its many functions, IL-12 is involved
in initiation of cell-mediated immune
responses, development and survival of Th1
cells, and down-regulation of Th2 immune
responses. One of the important aspects of
IL-12 is its ability to be produced very rapidly
after infection, which provides the cytokine
with the potential to inﬂuence Th1 cell devel-
opment (11). The suppressive effects of DEPs
on the production of IL-12 indicate that
DEP exposure might elicit an adverse influ-
ence on the development of T-cell–mediated
immunity. This may disrupt the balance of
Th1 and Th2 immune responses, resulting in
increased susceptibility to, and severity of,
pulmonary bacterial infection and, perhaps,
allergic sensitization as well. Our studies on
the effects of DEP exposure on T-cell–medi-
ated immunity in response to Listeria infec-
tion will be reported elsewhere.
In summary, this study demonstrates that
exposure to DEPs signiﬁcantly decreased the
rate of bacterial clearance from the lungs com-
pared with the air controls. Exposure to DEPs
attenuated Listeria-induced activation of AMs
and resulted in a diminished capacity in
phagocytosis and production of IL-1β, IL-12,
and TNF-α.
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Figure 5. Production of (A) IL-1β, (B) TNF-α, and (C) IL-12 by AMs from rats exposed to air or DEPs (50 and 100 mg/m3) with or without Listeria in responses to ex
vivo LPS stimulation. AMs harvested at 3 and 7 days postinfection were incubated in RPMI-1640 medium with 1 µg/mL of LPS for 24 hr. Concentrations of the
cytokines in the culture media were quantiﬁed and expressed as the mean ± SEM. 
*Signiﬁcantly different from the corresponding air controls, p < 0.05. #Signiﬁcantly different from the corresponding noninfected controls, p < 0.05.
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